157 related articles for article (PubMed ID: 31276952)
1. Synthesis, anti-diabetic evaluation and molecular docking studies of 4-(1-aryl-1H-1, 2, 3-triazol-4-yl)-1,4-dihydropyridine derivatives as novel 11-β hydroxysteroid dehydrogenase-1 (11β-HSD1) inhibitors.
Praveenkumar E; Gurrapu N; Kumar Kolluri P; Yerragunta V; Reddy Kunduru B; Subhashini NJP
Bioorg Chem; 2019 Sep; 90():103056. PubMed ID: 31276952
[TBL] [Abstract][Full Text] [Related]
2. Structural Insights and Docking Analysis of Adamantane-Linked 1,2,4-Triazole Derivatives as Potential 11β-HSD1 Inhibitors.
Osman DA; Macías MA; Al-Wahaibi LH; Al-Shaalan NH; Zondagh LS; Joubert J; Garcia-Granda S; El-Emam AA
Molecules; 2021 Sep; 26(17):. PubMed ID: 34500764
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of the N-methyl Derivatives of 2-Aminothiazol-4(5H)-one and Their Interactions with 11βHSD1-Molecular Modeling and in Vitro Studies.
Studzińska R; Kołodziejska R; Płaziński W; Kupczyk D; Kosmalski T; Jasieniecka K; Modzelewska-Banachiewicz B
Chem Biodivers; 2019 Jun; 16(6):e1900065. PubMed ID: 31012543
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and biological evaluation of 1,4-diaryl-1,4-dihydropyrazines as novel 11β-HSD1 inhibitors.
Duan X; Xin H; Yan H
Biol Pharm Bull; 2014; 37(5):840-6. PubMed ID: 24790006
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of picolinamides as potent inhibitors of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1).
Ryu JH; Kim S; Han HY; Son HJ; Lee HJ; Shin YA; Kim JS; Park HG
Bioorg Med Chem Lett; 2015 Feb; 25(3):695-700. PubMed ID: 25529735
[TBL] [Abstract][Full Text] [Related]
6. Novel 2-(Adamantan-1-ylamino)Thiazol-4(5
Studzińska R; Kupczyk D; Płaziński W; Baumgart S; Bilski R; Paprocka R; Kołodziejska R
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445315
[TBL] [Abstract][Full Text] [Related]
7. HIS-388, a novel orally active and long-acting 11β-hydroxysteroid dehydrogenase type 1 inhibitor, ameliorates insulin sensitivity and glucose intolerance in diet-induced obesity and nongenetic type 2 diabetic murine models.
Okazaki S; Takahashi T; Iwamura T; Nakaki J; Sekiya Y; Yagi M; Kumagai H; Sato M; Sakami S; Nitta A; Kawai K; Kainoh M
J Pharmacol Exp Ther; 2014 Oct; 351(1):181-9. PubMed ID: 25100752
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, molecular docking and in vitro evaluation of benzothiazole derivatives as 11β-hydroxysteroid dehydrogenase type 1 inhibitors.
Cabrera Pérez LC; Padilla-Martínez II; Cruz A; Correa Basurto J; Miliar García Á; Hernández Zavala AA; Gómez López M; Rosales Hernández MC
Mol Divers; 2020 Nov; 24(4):1-14. PubMed ID: 31664610
[TBL] [Abstract][Full Text] [Related]
9. Discovery of novel inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 by docking and pharmacophore modeling.
Yang H; Dou W; Lou J; Leng Y; Shen J
Bioorg Med Chem Lett; 2008 Feb; 18(4):1340-5. PubMed ID: 18242087
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of selective 11β-HSD1 inhibitors based on dammarane scaffold.
Shao LD; Bao Y; Shen Y; Su J; Leng Y; Zhao QS
Eur J Med Chem; 2017 Jul; 135():324-338. PubMed ID: 28458137
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of novel curcumin analogues for inhibition of 11β-hydroxysteroid dehydrogenase type 1 with anti-diabetic properties.
Yuan X; Li H; Bai H; Su Z; Xiang Q; Wang C; Zhao B; Zhang Y; Zhang Q; Chu Y; Huang Y
Eur J Med Chem; 2014 Apr; 77():223-30. PubMed ID: 24642565
[TBL] [Abstract][Full Text] [Related]
12. A novel derivatives of thiazol-4(5H)-one and their activity in the inhibition of 11β-hydroxysteroid dehydrogenase type 1.
Studzińska R; Kołodziejska R; Kupczyk D; Płaziński W; Kosmalski T
Bioorg Chem; 2018 Sep; 79():115-121. PubMed ID: 29738970
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and structure-activity relationship of 2-adamantylmethyl tetrazoles as potent and selective inhibitors of human 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1).
Ye XY; Yoon D; Chen SY; Nayeem A; Golla R; Seethala R; Wang M; Harper T; Sleczka BG; Apedo A; Li YX; He B; Kirby M; Gordon DA; Robl JA
Bioorg Med Chem Lett; 2014 Jan; 24(2):654-60. PubMed ID: 24360604
[TBL] [Abstract][Full Text] [Related]
14. Discovery of novel sulfonamides as potent and selective inhibitors against human and mouse 11β-hydroxysteroid dehydrogenase type 1.
Xia G; Liu L; Xue M; Liu H; Yu J; Li P; Chen Q; Xiong B; Liu X; Shen J
Mol Cell Endocrinol; 2012 Jul; 358(1):46-52. PubMed ID: 22410288
[TBL] [Abstract][Full Text] [Related]
15. Discovery and Biological Evaluation of Potent and Orally Active Human 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitors for the Treatment of Type 2 Diabetes Mellitus.
Koike T; Shiraki R; Sasuga D; Hosaka M; Kawano T; Fukudome H; Kurosawa K; Moritomo A; Mimasu S; Ishii H; Yoshimura S
Chem Pharm Bull (Tokyo); 2019; 67(8):824-838. PubMed ID: 31366832
[TBL] [Abstract][Full Text] [Related]
16. Anti-diabetic and anti-adipogenic effects of a novel selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor in the diet-induced obese mice.
Park JS; Rhee SD; Jung WH; Kang NS; Kim HY; Kang SK; Ahn JH; Kim KY
Eur J Pharmacol; 2012 Sep; 691(1-3):19-27. PubMed ID: 22760069
[TBL] [Abstract][Full Text] [Related]
17. 3-Amino-N-adamantyl-3-methylbutanamide derivatives as 11β-hydroxysteroid dehydrogenase 1 inhibitor.
Lee Y; Shin YJ; Ahn SK
Bioorg Med Chem Lett; 2014 Mar; 24(5):1421-5. PubMed ID: 24507919
[TBL] [Abstract][Full Text] [Related]
18. Discovery of adamantyl ethanone derivatives as potent 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) inhibitors.
Su X; Pradaux-Caggiano F; Thomas MP; Szeto MW; Halem HA; Culler MD; Vicker N; Potter BV
ChemMedChem; 2010 Jul; 5(7):1026-44. PubMed ID: 20486152
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and SAR of piperidyl-oxadiazoles as 11β-hydroxysteroid dehydrogenase 1 inhibitors.
Xia G; You X; Liu L; Liu H; Wang J; Shi Y; Li P; Xiong B; Liu X; Shen J
Eur J Med Chem; 2013 Apr; 62():1-10. PubMed ID: 23353742
[TBL] [Abstract][Full Text] [Related]
20. Searching for novel applications of the benzohomoadamantane scaffold in medicinal chemistry: Synthesis of novel 11β-HSD1 inhibitors.
Valverde E; Seira C; McBride A; Binnie M; Luque FJ; Webster SP; Bidon-Chanal A; Vázquez S
Bioorg Med Chem; 2015 Dec; 23(24):7607-17. PubMed ID: 26596711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
